Despite genomic similarity between the bulk tumor and the EPCAM+CD44+CD49f+ cells, principal component analysis demonstrated heterogeneity among bulk tumor regions, lymph nodes, as well as the derived EPCAM+CD44+CD49f+ subpopulations (Figure 3A). The gene discussed is CD44; the disease is neoplasm.